SL
BSX icon

Salomon & Ludwin’s Boston Scientific BSX Stock Holding History

Salomon & Ludwin’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.4K Buy
1,239
+262
+27% +$14.2K ﹤0.01% 504
2026
Q1 		$61.4K Sell
977
-61
-6% -$4.88K 0.01% 398
2025
Q4 		$99.1K Buy
1,038
+304
+41% +$29.8K 0.01% 241
2025
Q3 		$71.4K Buy
+734
New +$76K 0.01% 298

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Salomon & Ludwin's BSX Position: Q2 2026 in Review

Salomon & Ludwin increased its Boston Scientific (BSX) stake by 27% in Q2 2026, buying an estimated $14.2K and bringing the position to 1,239 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Salomon & Ludwin first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $99.1K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Salomon & Ludwin held 1,239 shares of Boston Scientific worth $53.4K as of Q2 2026.
  • Salomon & Ludwin bought 262 Boston Scientific shares in Q2 2026, an estimated $14.2K.
  • Boston Scientific made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #504 holding.
  • Salomon & Ludwin first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Boston Scientific position peaked at $99.1K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.